Bullish for PVRINOX: Lionsgate Play Boosts Theatrical Film Releases

Lionsgate Play is adopting a theatrical-first strategy in India, planning to release 10-12 premium Hollywood films annually in cinemas starting September 2026 before their digital streaming debut. This marks a significant shift from a direct-to-streaming model, emphasizing traditional theatrical distribution.

This strategy change is crucial for the Indian entertainment market as it signals renewed confidence in the theatrical experience, especially for international content. It could lead to increased footfall in multiplexes and potentially higher box office collections, benefiting the entire film exhibition value chain.

Multiplex chains like PVRINOX and INOXLEISUR are likely to see a positive impact due to a consistent pipeline of premium Hollywood content, which historically attracts significant audiences. This could translate into higher ticket sales and F&B revenues. Other media and entertainment companies might see indirect benefits from a more vibrant theatrical market.

Traders should monitor the actual release schedule and box office performance of these Lionsgate films starting September 2026. Also, watch for similar strategic shifts from other international studios and any commentary from multiplex operators regarding expected revenue boosts. Key resistance levels for PVRINOX and INOXLEISUR should be observed.

• •Lionsgate Play is shifting its India strategy to prioritize theatrical distribution.
• •Plans to release 10-12 premium Hollywood films annually starting September 2026.
• •Films will have a theatrical run before their exclusive streaming debut.
• •The aim is to enhance visibility and audience engagement.
• •Risk flag: Lower-than-expected box office performance of Hollywood films